Rituximab in the treatment of secondary-progressive multiple sclerosis

被引：0
|
作者：
Perrone, C. [1 ]
Berriosmorales, I. [1 ]
Beretich, B. [2 ]
Riskind, P. [1 ]
Ionete, C. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Maine Med Ctr, Portland, ME 04102 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P286
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [21] Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status
    Masek, Martin
    Vaneckova, Manuela
    Krasensky, Jan
    Danes, Jan
    Havrdova, Eva
    Hrebikova, Tereza
    Seidl, Zdenek
    NEUROENDOCRINOLOGY LETTERS, 2008, 29 (04) : 461 - 466
  • [22] Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis
    Francis, P. L.
    Jakubovic, R.
    O'Connor, P.
    Zhang, L.
    Eilaghi, A.
    Lee, L.
    Carroll, T. J.
    Mouannes-Srour, J.
    Feinstein, A.
    Aviv, R. I.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2013, 34 (01) : 62 - 67
  • [23] Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis
    Carotenuto, A.
    Costabile, T.
    Moccia, M.
    Falco, F.
    Scala, M. R.
    Russo, C., V
    Sacca, F.
    De Rosa, A.
    Lanzillo, R.
    Morra, V. Brescia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 1 - 6
  • [24] Comparative clinical immunologic analysis of the remittent and secondary-progressive course of multiple sclerosis
    Gusev, EI
    Belyaeva, IA
    Chekhonin, VP
    Demina, TL
    Boyko, AN
    Buglak, AV
    Gurina, OI
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2000, 100 (06): : 51 - 57
  • [25] CD5-positive B cell subsets in secondary-progressive multiple sclerosis
    Niino, M.
    Fukazawa, T.
    Minami, N.
    Amino, I.
    Tashiro, J.
    Fujiki, N.
    Doi, S.
    Kikuchi, S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 362 - 362
  • [26] Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
    Naegelin, Yvonne
    Naegelin, Peter
    von Felten, Stefanie
    Lorscheider, Johannes
    Sonder, Judith
    Uitdehaag, Bernard M. J.
    Scotti, Barbara
    Zecca, Chiara
    Gobbi, Claudio
    Kappos, Ludwig
    Derfuss, Tobias
    JAMA NEUROLOGY, 2019, 76 (03) : 274 - 281
  • [27] Rituximab in secondary progressive multiple sclerosis: a meta-analysis
    Intarakhao, Pasin
    Laipasu, Taksaporn
    Jitprapaikulsan, Jiraporn
    Apiraksattayakul, Natnasak
    Kosiyakul, Punchika
    Siritho, Sasitorn
    Prayoonwiwat, Naraporn
    Ongphichetmetha, Tatchaporn
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (10): : 2707 - 2718
  • [28] Extensive White Matter Dysfunction in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis
    Francis, P. L.
    Chia, T. L.
    Jakubovic, R.
    O'Connor, P.
    Lee, L.
    Feinstein, A.
    Aviv, R. I.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2014, 35 (10) : 1910 - 1915
  • [29] Rituximab in secondary-progressive MS: a two-year retrospective analysis
    Ionete, C.
    Perrone, C.
    Barton, B.
    Diiulio, M.
    Riskind, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 210 - 210
  • [30] Outcome of secondary progressive multiple sclerosis patients treated with rituximab or alemtuzumab
    Aguirre, C.
    Meca-Lallana, V.
    Sanchez, P.
    del Rio, B.
    Garcia-Vaz, F.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 157 - 157
12345